Publication date: Jan 15, 2025
This case report highlights the diagnostic and therapeutic complexities faced by a 56-year-old female with Good’s syndrome (GS), who presented with persistent Coronavirus Disease 2019 (COVID-19) infection alongside Aspergillus spp, cytomegalovirus, and Pseudomonas aeruginosa co-infection, which collectively contributed to severe pulmonary involvement. The report further emphasizes a multifaceted treatment approach, incorporating antivirals, antifungals, antimicrobials, immunoglobulins, and antifibrotic therapy, which ultimately led to an improvement in the patient’s condition. It underscored the intricate challenges of managing immunocompromised patients with multiple concurrent infections. The detailed diagnosis and treatment process of this complex case provides valuable insights to clinicians managing similar scenarios.
Concepts | Keywords |
---|---|
Antivirals | Case report |
Clinicians | COVID-19 |
Cytomegalovirus | Good’s syndrome |
Old | Polymicrobial infections |
Pulmonary |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | syndrome |
disease | MESH | COVID-19 |
disease | MESH | infection |
disease | MESH | polymicrobial infections |
disease | MESH | immunocompromised patients |
disease | IDO | process |